• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测三阴性乳腺癌预后的两个自噬相关基因的预后风险特征

A Prognostic Risk Signature of Two Autophagy-Related Genes for Predicting Triple-Negative Breast Cancer Outcomes.

作者信息

Yu Bing, Xing Zhimei, Tian Xiaoxuan, Feng Rui

机构信息

Department of Breast Surgery, Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, 300100, People's Republic of China.

State Key Laboratory of Component‑Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, People's Republic of China.

出版信息

Breast Cancer (Dove Med Press). 2024 Sep 2;16:529-544. doi: 10.2147/BCTT.S475007. eCollection 2024.

DOI:10.2147/BCTT.S475007
PMID:39246674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11379032/
Abstract

BACKGROUND

Triple-negative breast cancer (TNBC) is recognized as the most aggressive molecular subtype of breast cancer. Recent studies have highlighted the complex role of autophagy in the pathogenesis of TNBC.

METHODS

In this study, we evaluated 18,330 genes, including 1111 autophagy-related genes, (ARGs), across 579 TNBC samples from online databases. Differentially expressed ARGs in TNBC were identified using high-throughput RNA-seq data from the Cancer Genome Atlas (TCGA). Prognostic factors were examined through Cox regression and multivariate Cox analyses, with predictive efficacy assessed using receiver operating characteristic (ROC) curves. A nomogram integrating the risk signature with clinicopathological factors, such as TNM stage, was developed. Immunohistochemical analysis of clinical samples was also conducted.

RESULTS

EIF4EBP1 and NPAS3 were significantly correlated with prognostic outcomes in patients with TNBC. Multivariate Cox regression analysis demonstrated that the expression levels of these two genes were accurate predictors of disease progression in TNBC samples from TCGA and the GSE31519 dataset. The efficacy of this predictive model was validated using ROC curve analysis and calibration plots, confirming its ability to accurately estimate the 1-, 2-, and 3-year survival rates for individuals with TNBC. Additionally, EIF4EBP1 and NPAS3 expression influenced drug sensitivity in TNBC cell lines, with notably lower NPAS3 expression in TNBC tissues, particularly in Stage III cases. This study is the first to report NPAS3 expression in patients with TNBC.

CONCLUSION

The autophagy-related genes EIF4EBP1 and NPAS3 may serve as independent prognostic factors for individuals with TNBC.

摘要

背景

三阴性乳腺癌(TNBC)被认为是乳腺癌中最具侵袭性的分子亚型。最近的研究强调了自噬在TNBC发病机制中的复杂作用。

方法

在本研究中,我们从在线数据库评估了579个TNBC样本中的18330个基因,包括1111个自噬相关基因(ARGs)。使用来自癌症基因组图谱(TCGA)的高通量RNA测序数据鉴定TNBC中差异表达的ARGs。通过Cox回归和多变量Cox分析检查预后因素,并使用受试者工作特征(ROC)曲线评估预测效能。开发了一个将风险特征与临床病理因素(如TNM分期)相结合的列线图。还对临床样本进行了免疫组织化学分析。

结果

EIF4EBP1和NPAS3与TNBC患者的预后结果显著相关。多变量Cox回归分析表明,这两个基因的表达水平是TCGA和GSE31519数据集中TNBC样本疾病进展的准确预测指标。使用ROC曲线分析和校准图验证了该预测模型的效能,证实其能够准确估计TNBC个体的1年、2年和3年生存率。此外,EIF4EBP1和NPAS3的表达影响TNBC细胞系中的药物敏感性,TNBC组织中NPAS3的表达明显较低,尤其是在III期病例中。本研究首次报道了TNBC患者中NPAS3的表达。

结论

自噬相关基因EIF4EBP1和NPAS3可能是TNBC个体的独立预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/0e24d17f7b12/BCTT-16-529-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/f867147526e7/BCTT-16-529-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/27f05ea9ea2d/BCTT-16-529-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/76c281cc75ae/BCTT-16-529-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/716361018938/BCTT-16-529-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/393dcb074dd1/BCTT-16-529-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/0866c5a2a11d/BCTT-16-529-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/e02cf75b6de2/BCTT-16-529-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/a2bc21dd1fb4/BCTT-16-529-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/ada8a40fade6/BCTT-16-529-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/0cd375942fb1/BCTT-16-529-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/0af58535003f/BCTT-16-529-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/0e24d17f7b12/BCTT-16-529-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/f867147526e7/BCTT-16-529-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/27f05ea9ea2d/BCTT-16-529-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/76c281cc75ae/BCTT-16-529-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/716361018938/BCTT-16-529-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/393dcb074dd1/BCTT-16-529-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/0866c5a2a11d/BCTT-16-529-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/e02cf75b6de2/BCTT-16-529-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/a2bc21dd1fb4/BCTT-16-529-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/ada8a40fade6/BCTT-16-529-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/0cd375942fb1/BCTT-16-529-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/0af58535003f/BCTT-16-529-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/11379032/0e24d17f7b12/BCTT-16-529-g0012.jpg

相似文献

1
A Prognostic Risk Signature of Two Autophagy-Related Genes for Predicting Triple-Negative Breast Cancer Outcomes.用于预测三阴性乳腺癌预后的两个自噬相关基因的预后风险特征
Breast Cancer (Dove Med Press). 2024 Sep 2;16:529-544. doi: 10.2147/BCTT.S475007. eCollection 2024.
2
Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.基于自噬相关基因的三阴性乳腺癌预后风险模型的构建与验证
Front Oncol. 2022 Feb 4;12:829045. doi: 10.3389/fonc.2022.829045. eCollection 2022.
3
Prognostic and Therapeutic Values of Autophagy-related Genes in Triple-negative Breast Cancer.自噬相关基因在三阴性乳腺癌中的预后和治疗价值。
Recent Pat Anticancer Drug Discov. 2022;17(4):380-386. doi: 10.2174/1574892816666211130170149.
4
Autophagy-related prognostic signature for survival prediction of triple negative breast cancer.自噬相关预后标志物预测三阴性乳腺癌患者的生存情况。
PeerJ. 2022 Feb 9;10:e12878. doi: 10.7717/peerj.12878. eCollection 2022.
5
HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration.HSPA8 是三阴性乳腺癌的一个新的预后和免疫浸润相关的生物标志物。
Dis Markers. 2022 Nov 21;2022:8446857. doi: 10.1155/2022/8446857. eCollection 2022.
6
Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.预测三阴性乳腺癌发病机制和预后的潜在关键基因及通路的鉴定
Cancer Cell Int. 2019 Jun 28;19:172. doi: 10.1186/s12935-019-0884-0. eCollection 2019.
7
Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.鉴定和验证一种新型糖酵解相关基因签名,用于预测三阴性乳腺癌的预后和治疗反应。
Adv Ther. 2023 Jan;40(1):310-330. doi: 10.1007/s12325-022-02330-y. Epub 2022 Nov 1.
8
Nomogram based on autophagy related genes for predicting the survival in melanoma.基于自噬相关基因的列线图预测黑色素瘤患者的生存情况。
BMC Cancer. 2021 Nov 22;21(1):1258. doi: 10.1186/s12885-021-08928-9.
9
Development of an ubiquitin-proteasome system signature for predicting prognosis and providing therapeutic guidance for patients with triple-negative breast cancer.开发泛素-蛋白酶体系统特征以预测三阴性乳腺癌患者的预后并提供治疗指导。
J Gene Med. 2024 Jan;26(1):e3584. doi: 10.1002/jgm.3584. Epub 2023 Aug 22.
10
Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.用于预测口腔鳞状细胞癌生存的自噬相关基因特征及列线图的开发与验证
Front Oncol. 2020 Oct 16;10:558596. doi: 10.3389/fonc.2020.558596. eCollection 2020.

引用本文的文献

1
Genetic polymorphisms as predictors of the response of hepatocellular carcinoma patients to doxorubicin chemotherapy: a genome-wide association study.基因多态性作为肝细胞癌患者对阿霉素化疗反应的预测指标:一项全基因组关联研究
Front Pharmacol. 2025 Jun 4;16:1604473. doi: 10.3389/fphar.2025.1604473. eCollection 2025.
2
Construction of a prognostic model for autophagy-related LncRNAs in lung adenocarcinoma.肺腺癌中自噬相关长链非编码RNA预后模型的构建
Medicine (Baltimore). 2025 Apr 11;104(15):e42122. doi: 10.1097/MD.0000000000042122.
3
Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer.

本文引用的文献

1
Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer: A Systematic Review and Meta-analysis.BRCA 靶向治疗(多聚腺苷二磷酸核糖聚合酶抑制剂)在治疗 BRCA 突变型乳腺癌中的疗效和安全性:系统评价和荟萃分析。
Am J Clin Oncol. 2024 Nov 1;47(11):555-562. doi: 10.1097/COC.0000000000001120. Epub 2024 Jun 20.
2
The complex biology of aryl hydrocarbon receptor activation in cancer and beyond.芳烃受体激活在癌症及其他领域的复杂生物学。
Biochem Pharmacol. 2023 Oct;216:115798. doi: 10.1016/j.bcp.2023.115798. Epub 2023 Sep 9.
3
DNA methylation marker to estimate ovarian cancer cell fraction.
致癌蛋白CDC45在乳腺癌中的预后及免疫作用的功能分析与实验验证
Breast Cancer (Dove Med Press). 2025 Jan 9;17:11-25. doi: 10.2147/BCTT.S497975. eCollection 2025.
用于估计卵巢癌细胞分数的 DNA 甲基化标志物。
Med Oncol. 2022 Feb 23;39(5):78. doi: 10.1007/s12032-022-01679-y.
4
Five crucial prognostic-related autophagy genes stratified female breast cancer patients aged 40-60 years.五项关键的与预后相关的自噬基因对 40-60 岁女性乳腺癌患者进行分层。
BMC Bioinformatics. 2021 Dec 7;22(1):580. doi: 10.1186/s12859-021-04503-y.
5
The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019.1990年至2019年全球、区域和国家乳腺癌负担及趋势:全球疾病负担研究2019结果
Front Oncol. 2021 May 21;11:689562. doi: 10.3389/fonc.2021.689562. eCollection 2021.
6
GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA.GEPIA2021:将多种基于去卷积的分析整合到 GEPIA 中。
Nucleic Acids Res. 2021 Jul 2;49(W1):W242-W246. doi: 10.1093/nar/gkab418.
7
Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer.转移性三阴性乳腺癌的新兴治疗药物
Breast Cancer (Auckl). 2021 Mar 22;15:11782234211002491. doi: 10.1177/11782234211002491. eCollection 2021.
8
The Molecular and Microenvironmental Landscape of Glioblastomas: Implications for the Novel Treatment Choices.胶质母细胞瘤的分子与微环境格局:对新型治疗选择的启示
Front Neurosci. 2020 Nov 25;14:603647. doi: 10.3389/fnins.2020.603647. eCollection 2020.
9
A novel autophagy-related lncRNA prognostic risk model for breast cancer.一种新的与自噬相关的长链非编码 RNA 乳腺癌预后风险模型。
J Cell Mol Med. 2021 Jan;25(1):4-14. doi: 10.1111/jcmm.15980. Epub 2020 Nov 20.
10
Triple‑negative breast cancer therapy: Current and future perspectives (Review).三阴性乳腺癌治疗:现状和未来展望(综述)。
Int J Oncol. 2020 Dec;57(6):1245-1261. doi: 10.3892/ijo.2020.5135. Epub 2020 Oct 16.